Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day
When you get positive results and a kickstart toward a healthier, slimmer you, its often the motivation you need to keep going until you achieve your ultimate goal of losing 10, 20, 30 pounds or more.
After obtaining favorable results in the investigator-initiated Phase III trial JETALS, and following consultation with Tokushima University, Eisai submitted a new drug application for the treatment of ALS in Japan in January 2024, leading to its approval in September, 2024 and leading to the launch today
Haematological malignancies: Myeloproliferative disorders (polycythaemia vera, chronic myeloid leukaemia) and some lymphomas increase B12-binding proteins, particularly haptocorrin, raising measured serum levels
The same dose at 10mg/mL is 0.5mL
US$ 27.24
US$ 29.27
US$ 21.58